Involvement and Clinical Aspects of MicroRNA in OsteosarcomaReport as inadecuate

Involvement and Clinical Aspects of MicroRNA in Osteosarcoma - Download this document for free, or read online. Document in PDF available to download.


Department of Experimental Pathology, CHUV and University of Lausanne, 1011 Lausanne, Switzerland


Laboratory for Orthopaedic Research, Department of Orthopaedics, Balgrist University Hospital, University of Zurich, 8008 Zurich, Switzerland


Author to whom correspondence should be addressed.

Academic Editor: William Cho

Abstract Osteosarcoma OS is the most common primary bone cancer in children and adolescents, but its pathogenesis has been difficult to establish because of its well-known heterogeneous nature. OS has been associated with genetic and cytogenetic abnormalities, which include function-impairing mutations in tumor suppressors and the activation of oncogenes. OS tumorigenesis has been linked to alterations of several genes characterized by a high level of genetic instability and recurrent DNA amplifications and deletions. MicroRNAs miRNAs, 18–25-nucleotide noncoding RNAs, are critical for various biological processes like differentiation, cell growth and cell death. Dysregulation of miRNA expression leads to phenotypic and genotypic changes in cells, which leads to cancer. Studies on miRNAs have initiated a significant effect in both diagnosis and treatment of cancer. This review focuses on the current knowledge of clinical applications of miRNAs for the better diagnosis and management of OS. View Full-Text

Keywords: osteosarcoma; metastasis; microRNA; biomarker; cancer osteosarcoma; metastasis; microRNA; biomarker; cancer

Author: Ram Mohan Ram Kumar 1,* , Aleksandar Boro 2 and Bruno Fuchs 2



Related documents